STEVE ELMS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEVE ELMS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEVE ELMS. STEVE ELMS is Director in PERNIX THERAPEUTICS HOLDINGS, INC. ($GTA) and Director in Marker Therapeutics, Inc. ($MRKR) and Director in ADMA BIOLOGICS, INC. ($ADMA) and Director in Loxo Oncology, Inc. ($LOXO) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN) and Director in Cidara Therapeutics, Inc. ($CDTX).
Latest Insider Trading Transactions of STEVE ELMS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADMA, CDTX, LOXO, MRKR, GTA, ZSAN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | MRKR | Marker Therapeutic ... | ELMS STEVE | Director | Grant | A | 0.00 | 12,658 | 0 | 29,680 | 17 K to 29.7 K (+74.36 %) |
| Mar 18 2021 | MRKR | Marker Therapeutic ... | ELMS STEVE | Director | Buy | P | 1.75 | 1,142,857 | 2,000,000 | 3,142,857 | 2 M to 3.1 M (+57.14 %) |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | ELMS STEVE | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K | |
| Jun 29 2020 | ZSAN | Zosano Pharma Corp | ELMS STEVE | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K | |
| Jun 05 2020 | ZSAN | Zosano Pharma Corp | ELMS STEVE | Director | Option Exercise | A | 1.01 | 15,000 | 15,150 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Aug 08 2019 | MRKR | Marker Therapeutic ... | ELMS STEVE | Director | Option Exercise | A | 4.21 | 12,500 | 52,625 | 12,500 | |
| Jul 18 2019 | ZSAN | Zosano Pharma Corp | ELMS STEVE | Director | Option Exercise | A | 2.34 | 1,500 | 3,510 | 1,500 | |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | D | 180.98 | 8,750 | 1,583,575 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | D | 78.58 | 11,000 | 864,380 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | D | 24.18 | 7,812 | 188,894 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | D | 20.91 | 7,812 | 163,349 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | D | 13.00 | 15,625 | 203,125 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Sell | U | 235.00 | 2,038,920 | 479,146,200 | 2,038,920 | 4.1 M to 2 M (-50.00 %) |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 14 2018 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | A | 180.98 | 8,750 | 1,583,575 | 8,750 | |
| May 21 2018 | ZSAN | Zosano Pharma Corp | ELMS STEVE | Director | Option Exercise | A | 4.27 | 25,000 | 106,750 | 25,000 | |
| Jun 23 2017 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | A | 78.58 | 11,000 | 864,380 | 11,000 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 3.66 | 53,837 | 197,043 | 53,837 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Jun 13 2016 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | A | 24.18 | 7,812 | 188,894 | 7,812 | |
| May 31 2016 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 0.45 | 40,000 | 18,000 | 0 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Aug 18 2015 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 4.70 | 40,000 | 188,000 | 40,000 | |
| Jul 30 2015 | LOXO | Loxo Oncology, Inc ... | ELMS STEVE | Director | Option Exercise | A | 20.91 | 7,812 | 163,349 | 7,812 | |
| Apr 24 2015 | GTA | PERNIX THERAPEUTIC ... | ELMS STEVE | Director | Option Exercise | P | 11.47 | 2,500,000 | 28,675,000 | 2,500,000 | |
| Apr 22 2015 | CDTX | Cidara Therapeutic ... | ELMS STEVE | Director | Option Exercise | C | 0.00 | 8,928,572 | 0 | 0 | |
| Apr 22 2015 | CDTX | Cidara Therapeutic ... | ELMS STEVE | Director | Buy | C | 0.00 | 351,518 | 0 | 351,518 | 0 to 351.5 K |
Page: 1